VA
TMDX icon

Vident Advisory’s Transmedics TMDX Stock Holding History

Vident Advisory’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$222K Buy
+2,229
New +$291K ﹤0.01% 1640

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vident Advisory's TMDX Position: Q1 2026 in Review

Vident Advisory opened a new position in Transmedics (TMDX) in Q1 2026: 2,229 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #1640 among its holdings.

414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Vident Advisory held 2,229 shares of Transmedics worth $222K as of Q1 2026.
  • Transmedics was a new Vident Advisory position in Q1 2026.
  • Transmedics made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1640 holding.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.